Rob is a Head of Cell Therapy Research Unit at the San Diego Blood Bank and previously was the VP for R&D at Cellerant Therapeutics responsible for development of the antibody-based oncology program. Rob has extensive expertise in preclinical pharmacology, toxicology, and cell-based assays with over 30 years of academic and industry experience in preclinical research and development. He has held various positions of leadership, where he oversaw R&D supporting oncology development of drug candidates from early discovery through IND-enabling studies.